Wall W J
Department of Surgery, University Hospital, London, Ont.
CMAJ. 1988 Jul 1;139(1):21-8.
In this decade liver transplantation has been established as the preferred treatment for children and adults with irreversible end-stage liver disease. Biliary atresia in children and nonalcoholic cirrhosis in adults are the most common indications for the procedure. Transplantation currently plays only a minor role in the treatment of hepatic malignant disease. Blood group compatibility between donor and recipient is preferred, but histocompatibility matching (tissue typing) currently has no significant role in the selection of recipients. Approximately 70% of recipients survive for 1 year, and these patients have an excellent prospect of long-term survival. The emerging evidence indicates that the quality of life and rehabilitation of most liver recipients are good. The current success of liver transplantation can be attributed to critical selection of recipients, modern anesthetic and surgical techniques, improved perioperative care, accurate diagnosis of rejection and superior immunosuppression with cyclosporine.
在这十年中,肝移植已成为患有不可逆终末期肝病的儿童和成人的首选治疗方法。儿童的胆道闭锁和成人的非酒精性肝硬化是该手术最常见的适应症。目前,移植在肝脏恶性疾病的治疗中仅起次要作用。供体和受体之间的血型相容性是优选的,但组织相容性匹配(组织分型)目前在受体选择中没有显著作用。大约70%的受体存活1年,这些患者有良好的长期存活前景。新出现的证据表明,大多数肝移植受体的生活质量和康复情况良好。目前肝移植的成功可归因于受体的严格选择、现代麻醉和手术技术、围手术期护理的改善、排斥反应的准确诊断以及环孢素的卓越免疫抑制作用。